ValiRx plc (LON:VAL – Get Free Report)’s share price traded up 14.3% on Thursday. The stock traded as high as GBX 0.18 and last traded at GBX 0.16. 66,396,219 shares were traded during trading, an increase of 425% from the average daily volume of 12,638,085 shares. The stock had previously closed at GBX 0.14.
ValiRx Price Performance
The stock has a market cap of £2.51 million, a PE ratio of -0.46 and a beta of 0.59. The company has a 50 day moving average price of GBX 0.14 and a two-hundred day moving average price of GBX 0.22.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) EPS for the quarter. ValiRx had a negative return on equity of 71.49% and a negative net margin of 6,548.06%. As a group, equities analysts predict that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
- The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch
- MarketBeat Week in Review – 10/26 – 10/30
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
